Search Results - "Umehara, Shintaro"
-
1
Effects of Helicobacter pylori CagA protein on the growth and survival of B lymphocytes, the origin of MALT lymphoma
Published in Oncogene (13-11-2003)“…Helicobacter pylori (H. pylori) is a causative agent of gastrointestinal diseases such as atrophic gastritis and gastroduodenal ulcer. Infection of…”
Get full text
Journal Article -
2
Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura
Published in Annals of hematology (01-12-2005)“…Helicobacter pylori (HP) eradication therapy is a useful treatment for idiopathic thrombocytopenic purpura (ITP). Some investigators have also reported the…”
Get full text
Journal Article -
3
Successful Reduced-intensity Stem Cell Transplantation (RIST) for a Patient with Malignant Lymphoma and an Ileostomy
Published in Internal Medicine (01-05-2005)“…A 56-year-old man was admitted for treatment of non-Hodgkin’s lymphoma (NHL). He had undergone a partial small bowel and colon resection and had ileostomy due…”
Get full text
Journal Article -
4
Itraconazole capsules as antifungal prophylaxis for neutropenic patients with hematological malignancies from a single institution
Published in Japanese journal of antibiotics (01-12-2005)“…We have previously reported that itraconazole (ITCZ) at a dose of 200 mg/day is more effective than ITCZ at a dose of 100 mg/day and is safe for prophylaxis of…”
Get more information
Journal Article -
5
Single Photon Generation from an Impurity Center with Well-Defined Emission Energy in GaAs
Published in Japanese Journal of Applied Physics (01-04-2013)“…We studied optical properties of isoelectronic traps in nitrogen $\delta$-doped GaAs by micro-photoluminescence (μ-PL) spectroscopy. We found that these…”
Get full text
Journal Article -
6
Phase II Study of Rituximab Combined with Cladribine and Mitoxantrone in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
Published in Blood (16-11-2008)“…BACKGROUND. Synergistic or additive activities for rituximab and cladribine have been shown in preclinical studies. Indolent Non-Hodgkin's lymphoma (I-NHL)…”
Get full text
Journal Article -
7
Clinical Efficacy and Cost Benefit of Low-Dose Granulocyte Colony-Stimulating Factor after Standard Chemotherapy in Patients with Non-Hodgkin's Lymphoma
Published in Blood (16-11-2006)“…High costs of molecule-targeted drugs such as rituximab, ibritumomab and tositumomab have given rise to an economical issue for treating patients with…”
Get full text
Journal Article -
8
-
9
Long‐term follow‐up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities
Published in American journal of hematology (01-01-2005)“…A case of a leukemic transformation following a 27‐year history of idiopathic myelofibrosis (IMF) is presented. The patient had two chromosomal abnormalities:…”
Get full text
Journal Article -
10
Abnormal expansion of naïve B lymphocytes after unrelated cord blood transplantation – a case report
Published in Clinical and laboratory haematology (01-10-2006)“…Summary A 33‐year‐old woman underwent unrelated cord blood transplantation (U‐CBT) for myelodysplastic syndrome (MDS)‐related secondary AML. She showed…”
Get full text
Journal Article -
11